Skip to main content

Advertisement

Log in

Incidence and clinical correlation of anticentromere antibody in Thai patients

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Anticentromere antibodies (ACA) are useful in assessing and classifying patients with mild variant of systemic sclerosis called calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasias (CREST) syndrome. From their prognostic significance, we are interested in the prevalence and disease correlation in Thai patients. A total of 3,233 serum samples of patients with any musculoskeletal symptoms were sent for antinuclear antibody determination at Ramathibodi Immunology Laboratory Service between the years 1998 and 2001. Forty sera (1.23%) were ACA positive. These sera were from 27 patients with autoimmune diseases and 13 with nonautoimmune diseases. Among autoimmune group, scleroderma was the most common diagnosis (33.3%) with limited sclerosis being the most frequent variant. The percentages of autoimmune disease were almost the same among the low-titer (1:40) and the high-titer (1:640) groups. The study suggests that the prevalence of ACA in Thai patients is low. The presence of ACA detected in patients with vague musculoskeletal symptoms does not suggest a diagnosis of CREST syndrome. Even high-titer ACA can be found in nonautoimmune diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C (1980) Diversity of antinuclear antibodies in progressive systemic sclerosis: anticentromere antibody and its relationship to CREST syndrome. Arthritis Rheum 23:617–625

    Article  PubMed  CAS  Google Scholar 

  2. Fritzler MJ, Kinsella TD (1980) The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 69:520–526

    Article  PubMed  CAS  Google Scholar 

  3. Tuffanelli DL, McKeon F, Kleinsmith DM, Burnham TK, Kirschner M (1983) Anticentromere and anticentriole antibodies in the scleroderma spectrum. Arch Dermatol 119:560–566

    Article  PubMed  CAS  Google Scholar 

  4. Vazquez-Abad D, Grodzicky T, Senecal JL (1999) Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis. Clin Immunol 90:182–189

    Article  PubMed  CAS  Google Scholar 

  5. Chan HL, Lee YS, Hong HS, Kuo TT (1994) Anticentromere antibodies (ACA): clinical distribution and disease specificity. Clin Exp Dermatol 19:298–302

    Article  PubMed  CAS  Google Scholar 

  6. Sato S, Fujimoto M, Ihn H, Takehara K (1994) Antibodies to centromere and centriole in scleroderma spectrum disorders. Dermatology 189:23–26

    Article  PubMed  CAS  Google Scholar 

  7. Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI et al (1989) Prevalence of scleroderma spectrum disorders in the general populations of South Carolina. Arthritis Rheum 32:998–1002

    Article  PubMed  CAS  Google Scholar 

  8. Medsger TA (1994) Systemic sclerosis (scleroderma). In: Stein JH, Hutton JJ. Kohler Po et al (eds). Internal medicine, 4th edn. Mosby Year Book, St. Louise, MO, pp 2443–2449

    Google Scholar 

  9. Kallenberg CGM, Pastoor GW, Wouda AA et al (1982) Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis 41:382–387

    Article  PubMed  CAS  Google Scholar 

  10. Chorzelski TP, Jablonska S, Beutner EH, Blaszczyk M, Jarzabek-Chorzelska M, Kencha D et al (1985) Anticentromere antibody: an immunological marker of a subset of systemic sclerosis. Br J Dermatol 113:381–9

    Article  PubMed  CAS  Google Scholar 

  11. Powell FC, Winkelmann RK, Venencie-Lemarchand F, Spurbeck JL, Schroeter AL (1984) The anticentromere antibody: disease specificity and clinical significance. Mayo Clin Proc 59:700–706

    CAS  Google Scholar 

  12. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderrma). Arthritis Rheum 23:581–590

    Article  Google Scholar 

  13. Arnett FC, Edworthy SM, Block DA, Mcshane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  PubMed  CAS  Google Scholar 

  14. Vlachoyiannopauplos PG, Drosos AA, Wiik A, Moutsopoulos HM (1993) Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 32:297–301

    Article  PubMed  Google Scholar 

  15. Caramaschi P, Biasi D, Manzo T, Carletto A, Poli F, Bambara LM (1995) Anticentromere antibody-clinical associations: a study of 44 patients. Rheumatol Int 14:253–255

    Article  PubMed  CAS  Google Scholar 

  16. McCarty GA, Rice JR, Bembe ML, Barada FA Jr (1983) Anticentromere antibody. Clinical correlations and association with favorable prognosis in patients with scleroderma variants. Arthritis Rheum 26:1–7

    Article  PubMed  CAS  Google Scholar 

  17. Miller HM, Littlejohn GO, Davidson A, Jones B, Topliss DJ (1987) The clinical significance of the anticentromere antibody. Br J Rheumatol 26:17–21

    Article  PubMed  CAS  Google Scholar 

  18. Sun D, Martinez A, Sullivan KF, Sharp GC, Hoch SO (1996) Detection of anticentromere antibodies using recombinant human CENP-A protein. Arthritis Rheum 39:863–867

    Article  PubMed  CAS  Google Scholar 

  19. Martinez A, Sun D, Billings PB, Swiderek KM, Sullivan KF, Hoch SO (1998) Isolation and comparison of natural and recombinant human CENP-A autoantigen. J Autoimmun 11:611–619

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suchela Janwityanujit.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pakunpanya, K., Verasertniyom, O., Vanichapuntu, M. et al. Incidence and clinical correlation of anticentromere antibody in Thai patients. Clin Rheumatol 25, 325–328 (2006). https://doi.org/10.1007/s10067-005-0005-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-0005-4

Keywords

Navigation